CDKN1A and chromophobe renal cell carcinoma: It is tempting to speculate that a combination of loss of chromosomes 6, 10, and 17 and molecular two-hit disruption of PTEN and TP53 are the main drivers for the loss of CDKN1A expression and worse patient outcomes in chRCC.